Press "Enter" to skip to content

New patent expiration for NOVO drug MACRILEN

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for NOVO drug MACRILEN

Annual Drug Patent Expirations for MACRILEN
Annual Drug Patent Expirations for MACRILEN

Macrilen is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug.

This drug has sixty-four patent family members in thirty-one countries.

The generic ingredient in MACRILEN is macimorelin acetate. Two suppliers are listed for this compound. Additional details are available on the macimorelin acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for NOVO drug MACRILEN
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions